Results 281 to 290 of about 360,596 (308)

Periorale Dermatitis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
Andreas, Wollenberg, Thomas, Bieber, Thomas, Dirschka, Thomas, Luger, Michael, Meurer, Ehrhardt, Proksch, Michael P, Schön, Thomas, Schwarz, Diamant, Thaçi, Torsten, Zuberbier, Thomas, Werfel   +10 more
openaire   +2 more sources

Atopic dermatitis

Lancet, The, 2020
Sinead M Langan, Alan D Irvine, Stephan Weidinger   +2 more
exaly  

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Nature Reviews Drug Discovery, 2021
Thomas Bieber
exaly  

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Lancet, The, 2020
Rd Sinclair, Andreas Wollenberg, Michael J Cork   +2 more
exaly  

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet, The, 2021
E Guttman-Yassky, Ka Papp, Andrew Blauvelt   +2 more
exaly  

ATOPIJSKI DERMATITIS

2019
Atopijski dermatitis je česta kronična recidivirajuća upalna bolest koja se pojavljuje u osoba s atopijskom konstitucijom. Etiopatogeneza je složena i još nije u potpunosti. razjašnjena. Klinička slika se može nijenjati, od blagog to teškog oblika. Prirurčnik je nastao temeljem dugogodišnjeg kliničkog iskustva u liječenju djece i odraslih osoba.
Ljubojević Hadžavdić, Suzana, Pustišek, Nives   +1 more
openaire   +1 more source

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Atopic dermatitis therapy breakthrough on the horizon?

Nature Reviews Drug Discovery, 2014
Megan Cully
exaly  

ATOPIC DERMATITIS

Archives of Dermatology, 1958
openaire   +2 more sources

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Thomas Bieber, Andrew Blauvelt, Margitta Worm   +2 more
exaly